The objective of this study is to investigate whether intake of a diet with a high content of butyrate (from dairy fat) can affect blood FIAF concentration compared to a control diet. Further to examine whether high intake of inulin (a prebiotic) can increase the proportion of butyrate-producing bacteria in the gut and thereby affect blood FIAF concentration. In addition, the correlation between FIAF blood concentrations and resting energy expenditure, blood lipid profile and gut microbiota composition will be investigated. Furthermore, this study will investigate whether the source of FIAF can be determined. To this end, adipose tissue biopsies will be analyzed and an in vitro experiment with fecal water samples will be carried out. The study is a crossover randomized controlled trials with 3 arms. Each arm has a duration of 3 weeks. 20 overweight/obese subjects will be enrolled into the study and randomized to the order of interventions. Before and after each intervention period, blood samples will be collected and the participants will have their resting metabolic rate measured. At the end of each intervention period, the participants will collect feces for 5 consecutive days. In addition, adipose tissue biopsies will be taken after each intervention period.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
21
The participants will be given all dietary items in their diet. In the inulin arm, approximately 15 grams of inulin will be included in the diet.
The participants will be given all dietary items in their diet with no additional products.
The participants will be given all dietary items in their diet. In the whole milk arm, approximately 1 liter of whole milk will be included in the diet.
Department of Nutrition, Exercise and Sports
Frederiksberg, Copenhagen, Denmark
Changes in FIAF blood concentration
Time frame: 21 days
Changes in blood lipid profile including triglyceride, free fatty acid, low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), glycerol, butyrate
Time frame: 21 days
Changes in microbiotic composition and characterization of gut microbiota, including metabolites
Time frame: 21 days
Changes in short-chain fatty acid content of feces (butyrate, propionate and acetate)
Time frame: 21 days
Changes in resting energy expenditure/lipid oxidation
Time frame: 21 days
Changes in parameters involved in glucose metabolism
Time frame: 21 days
Changes in FIAF adipose tissue messenger ribonucleic acid (mRNA) levels
Time frame: 21 days
Changes in gene expression and protein concentration of genes/proteins related to obesity, lipid metabolism, adipocyte differentiation, hypoxia and FIAF signaling in adipose tissue
Time frame: 21 days
Changes in FIAF mRNA/protein expressed in or secreted from human intestinal cell lines
Time frame: 21 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.